Skip to Content

Nourianz Side Effects

Generic name: istradefylline

Medically reviewed by Drugs.com. Last updated on July 25, 2020.

Note: This document contains side effect information about istradefylline. Some of the dosage forms listed on this page may not apply to the brand name Nourianz.

For the Consumer

Applies to istradefylline: oral tablet

Side effects requiring immediate medical attention

Along with its needed effects, istradefylline (the active ingredient contained in Nourianz) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking istradefylline:

More common

  • Seeing, hearing, or feeling things that are not there
  • twitching, twisting, uncontrolled repetitive movements of tongue, lips, face, arms, or legs

Less common

  • Actions that are out of control
  • anxiety
  • attack, assault, force
  • confusion
  • confusion as to time, place, or person
  • delusions of persecution, mistrust, suspiciousness, or combativeness
  • dry mouth
  • false beliefs that cannot be changed by facts
  • hyperventilation
  • increased sexual urges
  • irregular heartbeats
  • irritability
  • restlessness
  • shaking
  • shortness of breath
  • talking, feeling, and acting with excitement
  • trouble sleeping
  • unusual excitement, nervousness, or restlessness

Side effects not requiring immediate medical attention

Some side effects of istradefylline may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

  • Difficulty having a bowel movement (stool)
  • nausea

Less common

For Healthcare Professionals

Applies to istradefylline: oral tablet

General

The most commonly reported adverse reactions have included dyskinesia, dizziness, constipation, nausea, hallucinations, and insomnia.[Ref]

Nervous system

Across clinical trials, dyskinesia occurred in 15% of patients receiving 20 mg once a day and 17% of patients receiving 40 mg once a day (compared to 8% for placebo); 1% of patients discontinued treatment because of dyskinesia.

Very common (10% or more): Dyskinesia (up to 17%)

Common (1% to 10%): Dizziness

Gastrointestinal

Common (1% to 10%): Constipation, nausea

Dermatologic

Common (1% to 10%): Rash

Metabolic

Common (1% to 10%): Decreased appetite, increased blood glucose

Hepatic

Common (1% to 10%): Blood alkaline phosphatase increased

Respiratory

Common (1% to 10%): Upper respiratory tract inflammation

Renal

Common (1% to 10%): Blood urea increased

Psychiatric

Common (1% to 10%): Hallucinations, abnormal thinking and behavior, insomnia

Rare (less than 0.1%): Impulse control disorder

Postmarketing reports: Increased libido

Across clinical trials, hallucinations occurred in 2% of patients receiving 20 mg once a day and 6% of patients receiving 40 mg once a day (compared to 3% for placebo); 1% of patients discontinued treatment because of hallucinations. Across clinical trials, abnormal thinking and behavior (paranoid ideation, delusions, confusion, mania, disorientation, aggressive behavior, agitation, or delirium) occurred in 1% of patients receiving 20 mg once a day and 2% of patients receiving 40 mg once a day (compared to 1% for placebo). Across clinical trials, 1 patient taking 40 mg/day reported an impulse control disorder. There were no reports in the patients taking 20 mg/day or placebo.

References

1. "Product Information. Nourianz (istradefylline)." Kyowa Kirin, Inc, Bedminster, NJ.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.